This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Ab. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Per Marin - Innovator in Metabolic Syndrome Treatment
Introduction
Per Marin is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of Metabolic Syndrome. His innovative approach has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Per Marin holds a patent for a method aimed at treating patients with Metabolic Syndrome. This method involves administering human growth hormone or a functional analog to patients exhibiting primary insulin resistance and lipoprotein aberrations or hypertension. The goal of this treatment is to effectively decrease the lipoprotein aberrations or hypertension experienced by these patients.
Career Highlights
Throughout his career, Per Marin has been associated with Pharmacia AB, a company known for its advancements in pharmaceutical research and development. His work has focused on innovative solutions that address complex health issues, showcasing his commitment to improving patient outcomes.
Collaborations
Per Marin has collaborated with esteemed colleagues such as Bengt-Ake Bengtsson and Lars Sjöström. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of metabolic health.
Conclusion
Per Marin's contributions to the treatment of Metabolic Syndrome highlight his role as an influential inventor in the medical field. His innovative methods and collaborations with other professionals underscore the importance of continued research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile